Search

Your search keyword '"George Bertsias"' showing total 95 results

Search Constraints

Start Over You searched for: Author "George Bertsias" Remove constraint Author: "George Bertsias" Topic immunology Remove constraint Topic: immunology
95 results on '"George Bertsias"'

Search Results

1. Annals of the Rheumatic Diseases collection on lupus nephritis (2019–2022): novel insights and advances in therapy

2. Microglia activation in the presence of intact blood–brain barrier and disruption of hippocampal neurogenesis via IL-6 and IL-18 mediate early diffuse neuropsychiatric lupus

3. 2022 EULAR points to consider for the measurement, reporting and application of IFN-I pathway activation assays in clinical research and practice

4. Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases

5. Treat to target in Behcet's disease

6. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases : a systematic literature review informing EULAR points to consider

7. EULAR study group on 'MHC-I-opathy'

8. Gender Equity in Academic Rheumatology, Current Status and Potential for Improvement: A Cross-Sectional Study to Inform an EULAR Task Force

9. Physician Global Assessment International Standardisation COnsensus in Systemic Lupus Erythematosus:the PISCOS study

10. Treatment of neuropsychiatric systemic lupus erythematosus: clinical challenges and future perspectives

12. Update οn the diagnosis and management of systemic lupus erythematosus

13. Cross-species transcriptome analysis for early detection and specific therapeutic targeting of human lupus nephritis

14. Dialogue: High-throughput studies in rheumatology: time for unsupervised clustering?

15. 2021 DORIS definition of remission in SLE:Final recommendations from an international task force

16. Treatment of lupus: more options after a long wait

17. Achieving remission or low disease activity is associated with better outcomes in patients with systemic lupus erythematosus: a systematic literature review

18. Remission or low disease activity at pregnancy onset are linked to improved foetal outcomes in women with systemic lupus erythematosus: results from a prospective observational study

19. Response to: Correspondence on 'Update on the diagnosis and management of systemic lupus erythematosus' by Fanouriakis

20. In an early SLE cohort the ACR-1997, SLICC-2012 and EULAR/ACR-2019 criteria classify non-overlapping groups of patients: use of all three criteria ensures optimal capture for clinical studies while their modification earlier classification and treatment

21. Cytokine targets in lupus nephritis: Current and future prospects

22. REDD1/autophagy pathway promotes thromboinflammation and fibrosis in human systemic lupus erythematosus (SLE) through NETs decorated with tissue factor (TF) and interleukin-17A (IL-17A)

23. Response to: 'Correspondence on 'Lupus or not? SLE Risk Probability Index (SLERPI): a simple, clinician-friendly machine learning-based model to assist the diagnosis of systemic lupus erythematosus' by Batu

24. Rituximab for refractory eosinophilic fasciitis: a case series with long-term follow-up and literature review

25. European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

26. Quality indicators for systemic lupus erythematosus based on the 2019 EULAR recommendations: development and initial validation in a cohort of 220 patients

27. NETs decorated with bioactive IL-33 infiltrate inflamed tissues and induce IFN-α production in patients with SLE

28. Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

29. Extensive fragmentation and re-organization of transcription in Systemic Lupus Erythematosus

30. 2019 update of the joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis

31. P0359CROSS-TISSUE AND MURINE-HUMAN COMPARATIVE TRANSCRIPTOME ANALYSES IDENTIFY TARGETABLE GENES FOR HUMAN SYSTEMIC LUPUS ERYTHEMATOUS AND LUPUS NEPHRITIS

32. Response to: 'Hydroxychloroquine is neutral in risk of chronic kidney disease in patients with systemic lupus erythematosus' by Wu

33. Management of lupus nephritis: a systematic literature review informing the 2019 update of the joint EULAR and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations

34. I13 Neutrophils and innate immunity in the pathogenesis of SLE

35. P107 Interferon-induced metabolic perturbations shape the inflammatory status of human monocytes: implications for innovative therapeutic engineering in SLE autoimmunity

36. Development and preliminary validation of the Behçet’s syndrome Overall Damage Index (BODI)

37. Epidemiology and burden of systemic lupus erythematosus in a Southern European population: data from the community-based lupus registry of Crete, Greece

38. A framework for remission in SLE

39. Population-based studies in systemic lupus erythematosus: immune thrombocytopenic purpura or ‘blood-dominant’ lupus?

40. Response to: 'Treatment of systemic lupus erythematosus: don't forget hydroxychloroquine' by Michaud

41. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

42. Immunometabolism: an overview and therapeutic prospects in autoimmune diseases

43. Lupus and the Brain: Advances in Neuropsychiatric Systemic Lupus Erythematosus

44. Changing paradigms in the treatment of systemic lupus erythematosus

45. Transcriptome reprogramming and myeloid skewing in haematopoietic stem and progenitor cells in systemic lupus erythematosus

46. POS0370 TYPE I INTERFERON PATHWAY ASSAYS IN PATIENTS WITH RHEUMATIC AND MUSCULOSKELETAL DISEASES - SYSTEMATIC LITERATURE REVIEW (SLR) AND DEVELOPMENT OF CONSENSUS TERMINOLOGY FROM A EULAR TASKFORCE

47. Elimination of Granulocytic Myeloid-Derived Suppressor Cells in Lupus-Prone Mice Linked to Reactive Oxygen Species-Dependent Extracellular Trap Formation

48. Update on the cellular and molecular aspects of lupus nephritis

49. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

50. P009 Transcriptomic analysis of plasmacytoid dendritic cells from rheumatoid arthritis patients reveals novel targets for therapy

Catalog

Books, media, physical & digital resources